N-2-BENZYLOXYPHENYL A-BENZILIDENE ISOBUTYRYLACETAMIDE

Light Yellow Solid

A intermediate of the metabolite of Atorvastin, a selective, competitive HMG-CoA reductase inhibitor. Atorvastin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hyper